Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 38: 2171-2183, 1992;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burtis, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burtis, W. J.

Clinical Chemistry, Vol 38, 2171-2183, Copyright © 1992 by American Association for Clinical Chemistry

Parathyroid hormone-related protein: structure, function, and measurement

WJ Burtis
Department of Medicine, West Haven Veterans Affairs Medical Center, CT 06516.

Parathyroid hormone-related protein (PTHRP) is a 139- to 173-amino-acid protein with N-terminal homology to parathyroid hormone (PTH). Initially isolated from tumors from patients with humoral hypercalcemia of malignancy, PTHRP appears to be of far more widespread physiological importance. Its complex gene is expressed in a surprising diversity of tissues. The primary amino acid sequences of both the PTH-like and non- PTH-like regions of the protein are highly conserved across species. In addition to classical and nonclassical PTH-like activities of the N- terminal region, other biological functions have been ascribed, including augmentation of calcium transport by midregion PTHRP and potent inhibition of bone resorption by a C-terminal peptide. There is emerging evidence that the protein undergoes extensive processing, including glycosylation and defined proteolytic cleavages. Several region-specific immunoassays are now capable of measuring circulating concentrations of PTHRP in patients with humoral hypercalcemia of malignancy. Molar concentrations of different regions may differ by more than an order of magnitude, reflecting diversity in processing and (or) metabolism. By analyzing the results of these assays, taking into account the specificities of known endoproteases, one can hypothesize about some of the endoproteolytic cleavages that occur in PTHRP metabolism. Clinically, selected PTHRP assays can be very helpful in diagnosing PTHRP-mediated hypercalcemia, but are not yet sufficiently sensitive to accurately measure normal concentrations of the protein.


The following articles in journals at HighWire Press have cited this article:


Home page
J. Cell Sci.Home page
C. Luparello, R. Sirchia, and D. Pupello
PTHrP [67-86] regulates the expression of stress proteins in breast cancer cells inducing modifications in urokinase-plasminogen activator and MMP-1 expression
J. Cell Sci., June 15, 2003; 116(12): 2421 - 2430.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. H. C. Lam, R. J. Thomas, K. L. Loveland, S. Schilders, M. Gu, T. J. Martin, M. T. Gillespie, and D. A. Jans
Nuclear Transport of Parathyroid Hormone (PTH)-Related Protein Is Dependent on Microtubules
Mol. Endocrinol., February 1, 2002; 16(2): 390 - 401.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
V. A. Tovar Sepulveda, X. Shen, and M. Falzon
Intracrine PTHrP Protects against Serum Starvation-Induced Apoptosis and Regulates the Cell Cycle in MCF-7 Breast Cancer Cells
Endocrinology, February 1, 2002; 143(2): 596 - 606.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
C. C. Capen
Overview of Structural and Functional Lesions in Endocrine Organs of Animals
Toxicol Pathol, January 1, 2001; 29(1): 8 - 33.
[Abstract] [PDF]


Home page
Clin. Chem.Home page
J.-C. Dumon, T. Jensen, B. Lueddecke, J. Spring, J. Barle, and J.-J. Body
Technical and Clinical Validation of an Immunoradiometric Assay for Circulating Parathyroid Hormone-related Protein
Clin. Chem., March 1, 2000; 46(3): 416 - 418.
[Full Text] [PDF]


Home page
Cancer Res.Home page
K. M. Dougherty, E. A. G. Blomme, A. J. Koh, J. E. Henderson, K. J. Pienta, T. J. Rosol, and L. K. McCauley
Parathyroid Hormone-related Protein as a Growth Regulator of Prostate Carcinoma
Cancer Res., December 1, 1999; 59(23): 6015 - 6022.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. H. C. Lam, L. J. Briggs, W. Hu, T. J. Martin, M. T. Gillespie, and D. A. Jans
Importin beta  Recognizes Parathyroid Hormone-related Protein with High Affinity and Mediates Its Nuclear Import in the Absence of Importin alpha
J. Biol. Chem., March 12, 1999; 274(11): 7391 - 7398.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Yamamoto, I. Morimoto, N. Yanagihara, K. Zeki, T. Fujihira, F. Izumi, H. Yamashita, and S. Eto
Parathyroid Hormone-Related Peptide-(1-34) [PTHrP- (1-34)] Induces Vasopressin Release from the Rat Supraoptic Nucleus in Vitro through a Novel Receptor Distinct from a Type I or Type II PTH/PTHrP Receptor
Endocrinology, May 1, 1997; 138(5): 2066 - 2072.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
N. T. Mandsager, A. S. Brewer, and L. Myatt
Vasodilator Effects of Parathyroid Hormone, Parathyroid Hormone-Related Protein, and Calcitonin Gene-Related Peptide in the Human Fetal-Placental Circulation
Reproductive Sciences, January 1, 1994; 1(1): 19 - 24.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by the American Association for Clinical Chemistry.